Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.
about
Synapse-specific contributions in the cortical pathology of schizophreniaThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaPyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuseA comparative study of variable selection methods in the context of developing psychiatric screening instrumentsSchizophrenia as a disorder of disconnectivityNovel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression.Neurodevelopment, GABA system dysfunction, and schizophreniaRepeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of ratsGene-environment interaction and the genetics of depression.Molecular mechanisms involved in depotentiation and their relevance to schizophrenia.Association between SNPs and gene expression in multiple regions of the human brainIntermittent Theta-Burst Transcranial Magnetic Stimulation Alters Electrical Properties of Fast-Spiking Neocortical Interneurons in an Age-Dependent Fashion.Target identification for CNS diseases by transcriptional profiling.Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls.A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.Transcranial direct current stimulation and neuroplasticity genes: implications for psychiatric disorders.Covariate adjusted classification trees.GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies.Mixture modeling with applications in schizophrenia research.Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs.Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia.Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.Hippocampal GABAergic Inhibitory Interneurons.Modeling interneuron dysfunction in schizophrenia.
P2860
Q26825577-858AD009-6A37-4961-BEE6-A04109FF2CD1Q28081110-A535A55F-6A8A-4FC1-B356-B1A558A16621Q30388341-8FFA871C-C69E-4C3C-B388-A39D8316B18AQ30447546-B569C17C-0F87-448E-8F9D-97A5020294B9Q33296977-7F3D6C93-FF22-4C41-BD7B-5CF15ABF5119Q33383204-F1A995FB-3DAD-4CC5-949B-7913EC3191ECQ33590705-4AF53BF8-B78E-41CC-AD17-5AFB386E87ECQ33632264-4CB1652F-B0AD-46B2-BFBF-3DF862C4C69CQ34002464-B2E779AE-B2AC-4377-868B-0F80A53EDD93Q34445123-FE2E0294-E642-4E95-A032-808F7321FA4CQ34675943-7C9996E6-31CD-4BE9-992D-B59E967665A4Q35024121-4573D725-01CF-4604-B240-25D8A3AEC8C6Q35790390-B80E7A17-E0E6-40AA-9055-C4983D093E67Q35925744-850B6AD1-D8EF-43A0-92DC-EB99DC8BA1E3Q36001595-CF3540F8-9EF5-4AE2-901B-ACD95D25BFC4Q36740255-9560E270-3EC0-46AF-978E-129D9CFB872DQ37175279-EF9DC6E4-9EA4-4181-9A26-60E96B786EC7Q37461052-1ED72B45-A0BF-4772-81F5-7BF4DC7E6B3EQ37501275-2C2C0498-0FF8-4A2C-B89D-0A3EFA661756Q38227967-F963A87C-B952-4E4F-9A57-7BC880ACD917Q38422738-5A3B3984-63EF-42C4-9397-7B6F9825AA0CQ38777031-C9BEA8CD-63ED-423C-9991-657B169680CDQ41370905-674C92CB-0A0B-46AC-95D7-093BFF8FDDACQ43132647-272B67CA-350B-4CDE-9BCB-5CF2A40B9F56Q44530077-54C82D2E-4584-48D6-B091-4C098AA60D2BQ44715726-CE291F35-A999-4413-A7F9-88ECD2D0F08DQ46418599-BF6C1DB5-FDE7-492F-8C16-58AE5756E7D3Q46461905-98B31E2A-4429-4F19-925C-4BAB94036D81Q47734973-A9A32561-F068-41E1-BC8E-F48DC6B4E70DQ48522858-ACA019AB-2EE9-40E5-842E-49AE4907A7EC
P2860
Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Molecular abnormalities in the ...... ost-mortem prefrontal markers.
@en
Molecular abnormalities in the ...... sification and Regression Tree
@nl
type
label
Molecular abnormalities in the ...... ost-mortem prefrontal markers.
@en
Molecular abnormalities in the ...... sification and Regression Tree
@nl
prefLabel
Molecular abnormalities in the ...... ost-mortem prefrontal markers.
@en
Molecular abnormalities in the ...... sification and Regression Tree
@nl
P2093
P2860
P356
P1433
P1476
Molecular abnormalities in the ...... ost-mortem prefrontal markers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4001034
P407
P577
2002-01-01T00:00:00Z